Skip to content


Lariam, Mefloquine (mefloquine) is a small molecule pharmaceutical. Mefloquine was first approved as Lariam on 1989-05-02. It is used to treat falciparum malaria, malaria, and vivax malaria in the USA. It is known to target adenosine receptor A1, adenosine receptor A2a, and purine nucleoside phosphorylase.
Trade Name Lariam, Mefloquine
Common Name Mefloquine
Indication falciparum malaria, malaria, vivax malaria
Drug Class
Get full access now